Icofungipen

Drug Profile

Icofungipen

Alternative Names: BAY 10-8888; PLD 118

Latest Information Update: 15 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Bayer; Bayer Yakuhin
  • Developer Bayer Yakuhin; PLIVA d.d.
  • Class Amino acids; Antifungals; Small molecules
  • Mechanism of Action Isoleucyl tRNA synthetase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Candidiasis; Vulvovaginal candidiasis

Most Recent Events

  • 20 May 2005 Phase-II clinical trials in Vulvovaginal candidiasis in USA (PO)
  • 31 Dec 2004 Phase-I clinical trials in Candidiasis in Germany (IV)
  • 31 Dec 2003 The first phase II trial has been successfully completed
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top